Covalent attachment
of a ferric hemoglobin (metHb) core
to three
human serum albumin molecules to form metHb-albumin clusters has previously
been used to develop an antidote for hydrogen sulfide poisoning. Lyophilization
is one of the most effective approaches to preserve protein pharmaceuticals
with minimum contamination and decomposition. However, there is concern
that lyophilized proteins may undergo pharmaceutical alteration on
reconstitution. This study investigated the pharmaceutical integrity
of metHb-albumin clusters on lyophilization and reconstitution with
three clinically available reconstitution fluids, (i) sterile water
for injection, (ii) 0.9% sodium chloride injection, and (iii) 5% dextrose
injection. The metHb-albumin clusters retained their physicochemical
properties and structural integrity on lyophilization and reconstitution
with sterile water for injection or 0.9% sodium chloride injection,
along with comparable hydrogen sulfide scavenging ability compared
to non-lyophilized metHb-albumin clusters. The reconstituted protein
completely rescued lethal hydrogen sulfide poisoning in mice. On the
other hand, lyophilized metHb-albumin clusters reconstituted with
5% dextrose injection showed physicochemical changes and a higher
mortality rate in mice subjected to lethal hydrogen sulfide poisoning.
In conclusion, lyophilization represents a potent preservation method
for metHb-albumin clusters if either sterile water for injection or
0.9% sodium chloride injection is used for reconstitution.